Posted by Michael Wonder on 05 Aug 2015
Eribulin mesylate (Halaven) is approved for women with locally advanced or metastatic breast cancer in whom the disease has progressed ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\1 \8 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \ \G \e \r \m \a \n \y \space \i \s \space \c \o \n \s \i \d \e \r \i \n \g \space \l \e \g \i \s \l \a \t \i \o \n \space \t \h \i \s \space \w \e \e \k \space \t \h \a \t \space \w \o \u \l \d \space \f \o \r \c \e \space \d \r \u \g \m \a \k \e \r \s \space \t \o \space \r \e \p \o \r \t \space \t \h \e \space \r \e \d \u \c \e \d \space \p \r \i \c \e \s \space \t \h \e \y \space \n \e \g \o \t \i \a \t \e " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
The drug dasabuvir (trade name Exviera) has been available since January 2015 for the treatment of adults with chronic hepatitis ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The introduction of the first disease management programmes was the starting point for providing a legal basis for evidence-based medicine ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Simoctocog alfa (trade name Nuwiq) has been approved since July 2014 for people with type A haemophilia, an inherited disorder ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive (“add-on”) therapy for adults and children ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\2 \space \M \a \y \space \2 \0 \1 \4 \space \- \space \S \o \f \o \s \b \u \v \i \r \space \h \a \s \space \b \e \e \n \space \a \v \a \i \l \a \b \l \e \space \s \i \n \c \e \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t \space \o \f \space \p \a \t \i \e \n \t \s \space \w \i \t \h \ \c \h \r \o \n \i \c \ \h \e \p \a \t \i \t \i \s \ \C \ \i \n \f \e \c \t \i \o \n \. \ \T \h \e \space \I \n \s \t \i \t \u \t \e \space \f \o \r \space \Q \u \a \l \i \t \y " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
Empagliflozin (trade name Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\A \space \w \e \e \k \space \a \f \t \e \r \space \G \e \r \m \a \n \y \' \s \space \F \e \d \e \r \a \l \space \J \o \i \n \t \space \C \o \m \m \i \t \t \e \e \space \( \G \- \B \A \) \space \i \s \s \u \e \d \space \i \t \s \space \f \i \n \a \l \space \b \e \n \e \f \i \t \space \a \s \s \e \s \s \m \e \n \t \space \o \f \space \D \P \P \- \4 \space \i \n \h \i \b \i \t \o \r \s \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t \space \o \f " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
Mirabegron (trade name: Betmiga) has been approved since December 2012 for the treatment of adults with overactive bladder. The Institute for Quality ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Is it worth $1 million to treat a potentially fatal genetic disease that causes painful swelling of the pancreas and ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\1 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \space \T \h \e \space \a \n \t \i \b \o \d \y \- \d \r \u \g \space \c \o \n \j \u \g \a \t \e \space \t \r \a \s \t \u \z \u \m \a \b \space \e \m \t \a \n \s \i \n \e \space \( \t \r \a \d \e \space \n \a \m \e \: \space \K \a \d \c \y \l \a \) \space \h \a \s \space \b \e \e \n \space \a \p \p \r \o \v \e \d \space \s \i \n \c \e \space \N \o \v \e \m \b \e \r \space \2 \0 \1 \3 \space \f \o \r \space \t \h \e " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
Albiglutide (trade name Eperzan) has been approved since March 2014 for adults with type 2 diabetes mellitus in whom diet ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\1 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \ \T \h \e \space \I \Q \W \i \G \ \r \e \a \s \s \e \s \s \e \d \space \t \h \e \space \a \n \t \i \v \i \r \a \l \space \d \r \u \g \space \c \o \m \b \i \n \a \t \i \o \n \space \r \i \l \p \i \v \i \r \i \n \e \/ \e \m \t \r \i \c \i \t \a \b \i \n \e \/ \t \e \n \o \f \o \v \i \r \. \space \I \n \space \e \a \r \l \y \space \2 \0 \1 \2 \, \space \t \h \e \space \c \o \m \b \i \n \a \t \i \o \n \space \w \a \s \space \a \p \p \r \o \v \e \d \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t " ..."]]
Read more →